|
|
|
|
home > abstracts >
Lee C, Straus WL, Balshaw R et al.
|
|
 |
Lee C, Straus WL, Balshaw R et al.
Arthritis & Rheumatism 2004;51:746-754.
To perform a meta-analysis comparing the efficacy and safety of recommended dosages of non-steroidal anti-inflammatory drugs (NSAIDs), including cyclooxygenase-2 selective inhibitors versus acetaminophen in the treatment of symptomatic hip and knee osteoarthritis, Medline and EMBASE searches were performed for original clinical trials directly comparing NSAIDs with acetaminophen. The scores for overall pain at rest and walking pain favoured the NSAID-treated group. Although NSAIDs were found to elevate the risk of withdrawals due to adverse events, the difference was not statistically significant. The study also found that NSAIDs are statistically superior in reducing rest and walking pain compared with acetaminophen for symptomatic osteoarthritis. Also, safety was not found to be statistically different between the NSAID- and acetaminophen-treated groups.
|
© Johnson & Johnson Inc. 2001-2010
This site is published by McNeil Consumer Healthcare, division of Johnson & Johnson Inc.
which is solely responsible for its content. It is intended for visitors from Canada only.
See our Legal Notice and Privacy Policy
Last updated: September 03rd, 2007
|
|
|
| |
|
 |
 |
 |
| |
The lecture on epidemiology also provides insights into the impact of musculoskeletal diseases.
|
 |
| |
|
|
 |
|
|
|
|
|
 |
 |
 |
| |
arthritisU.com
pays special attention to various aspects of osteoarthritis
(OA) from epidemiology to clinical practice. |
 |
| |
more |
|
 |
|
|
|
|
|
 |
 |
 |
 |
 |
|
|
|